2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Arthritis and Rheumatism

Volumn 62, Issue 9, 2010, Pages 2569-2581

  Aletaha, Daniel ^a   Neogi, Tuhina ^b   Silman, Alan J ^c   Funovits, Julia ^a   Felson, David T ^b   Bingham III, Clifton O ^d   Birnbaum, Neal S ^e   Burmester, Gerd R ^f   Bykerk, Vivian P ^g   Cohen, Marc D ^h   Combe, Bernard ⁱ   Costenbader, Karen H ^j   Dougados, Maxime ^k   Emery, Paul ^l   Ferraccioli, Gianfranco ^m   Hazes, Johanna M W ⁿ   Hobbs, Kathryn ^o   Huizinga, Tom W J ^p   Kavanaugh, Arthur ^q   Kay, Jonathan ^r   Kvien, Tore K ^s   Laing, Timothy ^t   Mease, Philip ^u   Ménard, Henri A ^v   Moreland, Larry W ^w   Naden, Raymond L ^x   Pincus, Theodore ^y   Smolen, Josef S ^a   Stanislawska Biernat, Ewa ^z   Symmons, Deborah ^aa   Tak, Paul P ^ab   Upchurch, Katherine S ^r   Vencovský, Jiří ^ac   Wolfe, Frederick ^ad   Hawker, Gillian ^g   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Arthritis Research UK   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY OF TORONTO   (Canada)

^h NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

ⁱ UNIV MONTPELLIER   (France)

^j HARVARD UNIVERSITY   (United States)

^k Cochin Hospital Assistance Publique Hôpitaux de Paris Paris Descartes University ^*  (France)

^l UNIVERSITY OF LEEDS   (United Kingdom)

^m CATHOLIC UNIVERSITY   (Italy)

ⁿ ERASMUS MEDICAL CENTER   (Netherlands)

^o UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^p LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^s DIAKONHJEMMET HOSPITAL   (Norway)

^t UNIVERSITY OF MICHIGAN   (United States)

^u UNIVERSITY OF WASHINGTON   (United States)

^v MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^w UNIVERSITY OF PITTSBURGH   (United States)

^x MINISTRY OF HEALTH   (New Zealand)

^y NYU HOSPITAL FOR JOINT DISEASES   (United States)

^z INSTITUTE OF RHEUMATOLOGY   (Poland)

^aa UNIVERSITY OF MANCHESTER   (United Kingdom)

^ab UNIVERSITY OF AMSTERDAM   (Netherlands)

^ac INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^ad UNIVERSITY OF KANSAS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN M; METHOTREXATE; RHEUMATOID FACTOR;

ACROMIOCLAVICULAR JOINT; CARPOMETACARPAL JOINT; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; GENETIC ASSOCIATION; GOLD STANDARD; HEALTH CARE ORGANIZATION; HUMAN; INTERPHALANGEAL JOINT; JOINT EXAMINATION; METACARPOPHALANGEAL JOINT; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; PROXIMAL INTERPHALANGEAL JOINT; RATING SCALE; REVIEW; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY; STERNOCLAVICULAR JOINT; SYNOVITIS; TEMPOROMANDIBULAR JOINT; VALIDATION STUDY; VALIDITY; ACUTE PHASE RESPONSE; ALGORITHM; ARTHRITIS, RHEUMATOID; CLASSIFICATION; CLINICAL TRIAL; COMPLICATION; EARLY DIAGNOSIS; EUROPE; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; MULTICENTER STUDY; NOMENCLATURE; NORTH AMERICA; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TIME;

ACUTE-PHASE REACTION; ALGORITHMS; ARTHRITIS, RHEUMATOID; EARLY DIAGNOSIS; EUROPE; HUMANS; INTERNATIONAL COOPERATION; NORTH AMERICA; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; SYNOVITIS; TERMINOLOGY AS TOPIC; TIME FACTORS;

EID: 77956055481     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27584     Document Type: Review

References (31)

1. Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1:1108-11.
2. Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986;29:706-14.
3. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72. (Pubitemid 14067781)
4. Isomaki H. Long-term outcome of rheumatoid arthritis. Scand J Rheumatol Suppl 1992;95:3-8.
5. Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl 1996;44:13-22.
6. Aho K, Heliovaara M, Maatela J, Tuomi T, Palusuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991;18:1282-4.
7. Aho K, von Essen R, Kurki P, Palusuo T, Heliovaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993;20:1278-81. (Pubitemid 23310975)
8. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MM, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6.
9. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9. (Pubitemid 37280601)
10. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423;356-61.
11. Smolen JS, Aletaha D, Koeller M, Weisman M, Emery P. New therapies for the treatment of rheumatoid arthritis. Lancet 2007;370:1861-74. (Pubitemid 350180008)
12. Bohndorf K, Schalm J. Diagnostic radiography in rheumatoid arthritis: benefits and limitations. Baillieres Clin Rheumatol 1996;10:399-407. (Pubitemid 26302505)
13. Van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 1995;34 Suppl 2:74-8.
14. Plant MJ, Jones PW, Saklatvala J, Ollier WE, Dawes PT. Patterns of radiological progression in rheumatoid arthritis: results of an 8 year prospective study. J Rheumatol 1998;25:417-26. (Pubitemid 28109339)
15. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82. (Pubitemid 28459915)
16. Machold KP, Stamm TA, Eberl GJ, Nell VK, Dunky A, Uffmann M, et al. Very recent onset arthritis: clinical, laboratory, and radiological findings during the first year of disease. J Rheumatol 2002;29:2278-87. (Pubitemid 35266017)
17. Bijlsma JW, Weinblatt ME. Optimal use of methotrexate: the advantages of tight control. Ann Rheum Dis 2007;66:1409-10.
18. Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS. Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritis [review]. Clin Exp Rheumatol 2003;21 Suppl 31:S179-85.
19. Visser K, van der Heijde D. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis 2009;68:1094-9.
20. Doan T, Massarotti E. Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol 2005;45:751-62. (Pubitemid 40875327)
21. Van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with "second-line" antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996;124:699-707.
22. Bukhari MA, Wiles NJ, Lunt M, Harrison BJ, Scott DG, Symmons DP, et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum 2003;48:46-53. (Pubitemid 36091646)
23. Van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007;56:1424-32. (Pubitemid 46764069)
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, et al. The American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report Phase 1. Ann Rheum Dis 2010;69:1589-95
26. Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, et al. The American College of Rheumatology/European League Against Rheumatism Classification Criteria for Rheumatoid Arthritis: Phase 2 methodological report. Arthritis Rheum 2010;62:2582-91.
27. Van der Helm-van Mil AH, Detert J, le Cessie S, Filer A, Bastain H, Burmester GR, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum 2008;58:2241-7.
28. Hyrich KL, Symmons DP, Silman AJ, OMERACT 7 Special Interest Group. Reconciling subject differences in recruitment to clinical trials and clinical practice. J Rheumatol 2005;32:2475-6.
29. Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005;52:3433-8. (Pubitemid 41612209)
30. Thabet MM, Huizinga TW, van der Heijde DM, van der Helm-van Mil AH. The prognostic value of baseline erosions in undifferentiated arthritis. Arthritis Res Ther 2009;11:R155.
31. Aggarwal R, Liao K, Nair R, Ringold S, Costenbander KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis [review]. Arthritis Rheum 2009;61:1472-83.